Contact this trialFirst, we need to learn more about you.
Kinase Inhibitor
Dabrafenib + Trametinib + Hydroxychloroquine for Brain Tumor
Recruiting1 awardPhase 1 & 2
Chicago, Illinois
This trial is designed to study the side effects and efficacy of adding hydroxychloroquine to dabrafenib and/or trametinib in children with brain tumors that have progressed or returned while receiving a similar agent.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.